Quest Diagnostics IncorporatedQuest Diagnostics IncorporatedQuest Diagnostics Incorporated

Quest Diagnostics Incorporated

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪18.16 B‬USD
7.52USD
‪850.00 M‬USD
‪9.25 B‬USD
‪111.06 M‬
Beta (1Y)
0.17
Employees (FY)
‪48 K‬
Change (1Y)
‪−1 K‬ −2.04%
Revenue / Employee (1Y)
‪192.75 K‬USD
Net income / Employee (1Y)
‪17.71 K‬USD

About Quest Diagnostics Incorporated


CEO
James E. Davis
Headquarters
Secaucus
Founded
1967
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
DGX.GL
Quest Diagnostics Incorporated 5.75% 30-JAN-2040
Yield to maturity
5.86%
Maturity date
Jan 30, 2040
US74834LAY6
QUEST DIAGNOSTICS 15/45
Yield to maturity
5.72%
Maturity date
Mar 30, 2045
QDIB
QUEST DIAGNOSTICS 15/25
Yield to maturity
5.45%
Maturity date
Mar 30, 2025
DGX5874569
Quest Diagnostics Incorporated 5.0% 15-DEC-2034
Yield to maturity
5.16%
Maturity date
Dec 15, 2034
DGX4986719
Quest Diagnostics Incorporated 2.8% 30-JUN-2031
Yield to maturity
5.13%
Maturity date
Jun 30, 2031
DGX.GJ
Quest Diagnostics Incorporated 6.95% 01-JUL-2037
Yield to maturity
5.06%
Maturity date
Jul 1, 2037
DGX4923784
Quest Diagnostics Incorporated 2.95% 30-JUN-2030
Yield to maturity
5.03%
Maturity date
Jun 30, 2030
DGX5678099
Quest Diagnostics Incorporated 6.4% 30-NOV-2033
Yield to maturity
4.93%
Maturity date
Nov 30, 2033
DGX5874568
Quest Diagnostics Incorporated 4.625% 15-DEC-2029
Yield to maturity
4.78%
Maturity date
Dec 15, 2029
DGX4807226
Quest Diagnostics Incorporated 4.2% 30-JUN-2029
Yield to maturity
4.71%
Maturity date
Jun 30, 2029
DGX5874579
Quest Diagnostics Incorporated 4.6% 15-DEC-2027
Yield to maturity
4.59%
Maturity date
Dec 15, 2027

Explore more bonds 

Frequently Asked Questions


The current price of DGX is 162.19 USD — it has decreased by −0.39% in the past 24 hours. Watch Quest Diagnostics Incorporated stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Quest Diagnostics Incorporated stocks are traded under the ticker DGX.
DGX stock has fallen by −1.01% compared to the previous week, the month change is a 3.91% rise, over the last year Quest Diagnostics Incorporated has showed a 18.09% increase.
We've gathered analysts' opinions on Quest Diagnostics Incorporated future price: according to them, DGX price has a max estimate of 185.00 USD and a min estimate of 145.00 USD. Watch DGX chart and read a more detailed Quest Diagnostics Incorporated stock forecast: see what analysts think of Quest Diagnostics Incorporated and suggest that you do with its stocks.
DGX reached its all-time high on Dec 31, 2021 with the price of 174.16 USD, and its all-time low was 3.31 USD and was reached on Dec 18, 1996. View more price dynamics on DGX chart.
See other stocks reaching their highest and lowest prices.
DGX stock is 0.98% volatile and has beta coefficient of 0.17. Track Quest Diagnostics Incorporated stock price on the chart and check out the list of the most volatile stocks — is Quest Diagnostics Incorporated there?
Today Quest Diagnostics Incorporated has the market capitalization of ‪18.16 B‬, it has increased by 2.15% over the last week.
Yes, you can track Quest Diagnostics Incorporated financials in yearly and quarterly reports right on TradingView.
Quest Diagnostics Incorporated is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
DGX earnings for the last quarter are 2.30 USD per share, whereas the estimation was 2.26 USD resulting in a 1.60% surprise. The estimated earnings for the next quarter are 2.19 USD per share. See more details about Quest Diagnostics Incorporated earnings.
Quest Diagnostics Incorporated revenue for the last quarter amounts to ‪2.49 B‬ USD, despite the estimated figure of ‪2.43 B‬ USD. In the next quarter, revenue is expected to reach ‪2.58 B‬ USD.
DGX net income for the last quarter is ‪225.00 M‬ USD, while the quarter before that showed ‪228.00 M‬ USD of net income which accounts for −1.32% change. Track more Quest Diagnostics Incorporated financial stats to get the full picture.
Yes, DGX dividends are paid quarterly. The last dividend per share was 0.75 USD. As of today, Dividend Yield (TTM)% is 1.82%. Tracking Quest Diagnostics Incorporated dividends might help you take more informed decisions.
Quest Diagnostics Incorporated dividend yield was 2.06% in 2023, and payout ratio reached 37.76%. The year before the numbers were 1.69% and 33.07% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 2, 2024, the company has ‪48.00 K‬ employees. See our rating of the largest employees — is Quest Diagnostics Incorporated on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Quest Diagnostics Incorporated EBITDA is ‪1.82 B‬ USD, and current EBITDA margin is 19.35%. See more stats in Quest Diagnostics Incorporated financial statements.
Like other stocks, DGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Quest Diagnostics Incorporated stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Quest Diagnostics Incorporated technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Quest Diagnostics Incorporated stock shows the buy signal. See more of Quest Diagnostics Incorporated technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.